29SU
BA3.2.2 SARS-CoV-2 Spike
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B, C (A, B, C) | Spike glycoprotein | polymer | 1144 | 126996.1 | 3 | UniProt (A0A7S6KRH9) | Homo sapiens (human) | S glycoprotein,E2,Peplomer protein |
| 2 | AA, D, E, F, G... (C, A, B) | 2-acetamido-2-deoxy-beta-D-glucopyranose | non-polymer | 221.2 | 24 | Chemie (NAG) PubChem (24139) |
Sequence modifications
A, B, C: 1 - 1134 (UniProt: A0A7S6KRH9)
| PDB | External Database | Details |
|---|---|---|
| Leu 9 | Pro 9 | conflict |
| Thr 21 | Arg 21 | conflict |
| Leu 26 | Pro 26 | conflict |
| Val 67 | Ala 67 | conflict |
| Ile 93 | Thr 95 | conflict |
| Thr 99 | Ile 101 | conflict |
| Ser 143 | Phe 150 | conflict |
| Lys 150 | Asn 157 | conflict |
| Phe 158 | Ser 165 | conflict |
| Thr 173 | Lys 180 | conflict |
| Ile 198 | Leu 205 | conflict |
| Ala 201 | - | insertion |
| Ser 202 | - | insertion |
| Asp 203 | - | insertion |
| Thr 204 | - | insertion |
| Ser 219 | Pro 244 | conflict |
| Val 313 | Ile 319 | conflict |
| Tyr 326 | Gly 332 | conflict |
| Pro 335 | Ala 341 | conflict |
| Thr 343 | Lys 349 | conflict |
| Phe 358 | Ser 364 | conflict |
| Pro 360 | Ser 366 | conflict |
| Phe 362 | Ser 368 | conflict |
| Lys 390 | Arg 396 | conflict |
| Asn 392 | Asp 398 | conflict |
| Ser 395 | Arg 401 | conflict |
| Asn 404 | Lys 410 | conflict |
| Ser 422 | Ala 428 | conflict |
| Arg 427 | Asn 433 | conflict |
| Ala 432 | Val 438 | conflict |
| Asp 433 | Gly 439 | conflict |
| Trp 439 | Leu 445 | conflict |
| Lys 447 | Asn 453 | conflict |
| Asn 464 | Ser 470 | conflict |
| Asn 465 | Thr 471 | conflict |
| Val 470 | Ala 476 | conflict |
| Lys 471 | Glu 477 | conflict |
| Ser 483 | Gly 489 | conflict |
| Arg 485 | Gln 491 | conflict |
| Tyr 488 | Asn 494 | conflict |
| Asn 516 | Lys 522 | conflict |
| Asp 541 | Glu 547 | conflict |
| Ser 562 | Ala 568 | conflict |
| Asp 570 | Glu 576 | conflict |
| Gly 601 | Asp 607 | conflict |
| Arg 612 | His 618 | conflict |
| Lys 628 | Asn 634 | conflict |
| Gly 629 | Val 635 | conflict |
| Lys 641 | Glu 647 | conflict |
| Tyr 642 | His 648 | conflict |
| Arg 666 | Asn 672 | conflict |
| His 668 | Pro 674 | conflict |
| Gly 669 | Arg 675 | conflict |
| Ser 670 | Arg 676 | conflict |
| Ser 672 | Arg 678 | conflict |
| Asp 675 | Ala 681 | conflict |
| Leu 691 | Ser 697 | conflict |
| Lys 751 | Asn 757 | conflict |
| Thr 782 | Lys 788 | conflict |
| Tyr 783 | Asp 789 | conflict |
| Lys 839 | Ala 845 | conflict |
| Phe 926 | Ser 932 | conflict |
| His 941 | Gln 947 | conflict |
| Lys 956 | Asn 962 | conflict |
| Pro 973 | Lys 979 | conflict |
| Pro 974 | Val 980 | conflict |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 3 |
| Total formula weight | 380988.3 | |
| Non-Polymers* | Number of molecules | 24 |
| Total formula weight | 5309.0 | |
| All* | Total formula weight | 386297.3 |
